Randomized Trial of Afatinib Plus Cetuximab Versus Afatinib Alone for First-Line Treatment of <i>EGFR</i>-Mutant Non-Small-Cell Lung Cancer: Final Results From SWOG S1403
SWOG Cancer Research Network
Sarah B Goldberg; Mary W Redman; Rogerio Lilenbaum; Katerina Politi; Thomas E Stinchcombe; Leora Horn; Everett H Chen; Sandeep H Mashru; Scott N Gettinger; Mary Ann Melnick; Roy S Herbst; Megan A Baumgart; Jieling Miao; James Moon; Karen Kelly; David R Gandara
SWOG Statistical Center, Seattle, WA. ; SWOG Statistical Center, Seattle, WA.